Six of these genes were usually underexpressed (RUNDC3B, ANGPT2, PHLDA2, CAV2, EDNRA, and SCG2) in non-aggressive/non-recurrent tumors and overexpressed in more aggressive/recurrent meningiomas. This evidence concerns the gene RUNDC3B and meningioma.